Compare ZLAB & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | SXI |
|---|---|---|
| Founded | 2013 | 1955 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.2B |
| IPO Year | 2017 | 1994 |
| Metric | ZLAB | SXI |
|---|---|---|
| Price | $17.64 | $278.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $49.60 | ★ $289.67 |
| AVG Volume (30 Days) | ★ 654.4K | 169.4K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ 6.98 |
| Revenue | $460,156,000.00 | ★ $604,535,000.00 |
| Revenue This Year | $9.75 | $14.87 |
| Revenue Next Year | $26.03 | $6.07 |
| P/E Ratio | ★ N/A | $39.39 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $147.75 |
| 52 Week High | $44.34 | $284.71 |
| Indicator | ZLAB | SXI |
|---|---|---|
| Relative Strength Index (RSI) | 36.14 | 60.79 |
| Support Level | $16.88 | $243.26 |
| Resistance Level | $19.64 | $281.03 |
| Average True Range (ATR) | 0.82 | 8.22 |
| MACD | -0.17 | 2.90 |
| Stochastic Oscillator | 1.61 | 92.89 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.